SBP solbec pharmaceuticals limited

earnings

  1. skint
    5,996 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    29/04/04
    09:29
    Post #: 451506
    Imclone have just announced their 1st Qtr 2004 earnings . Revenues have rocketed to 109.6 million USD with a net of 62.7 million USD . All this on the sales of their new drug for metastatic colorectal cancer ,erbitux . This is a marginal drug at best , with response time in combination with chemo of 5.7 months before disease progression and 1.5 months as a stand alone treatment .
    That looks ordinary compared to what Solbec were seeing in their special access patients .
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.